Spinal Cord Injury Network USA (SCINetUSA)

[Jim]

The trial was approved by the FDA and was getting ready to launch when Covid hit. This shut it down, then the trial sponsor, StemCyte, backed out. Wise then found new sources of umbilical cord blood, and submitted a new IND to the FDA. Because we are using a new sources of cells, must prove the cells are safe. This means conducting an animal study that will cost over a million. About 5 years ago, Wise started a company to collect umbilical cord blood to use for sci and other disorders. Mononuclear Therapeutics is the new sponsor f the trial. Wise will use the profits to fund trials. He is working hard to raise the 20+
million for the trial.

[crispy1981]

In the video it was mentioned there are a few clinics offering 6/6/6. I recall one was in floriada where I live. Can you share the name of the facility?

thanks

Yes, I'm aware of the expense and I'm not saying I could afford 6,6,6 but perhaps a modified/shorter version. There is a clinic in France doing someting similar. The doctor leading their therapy suggested they have a way to determine if someone has any residual fibers that are still intact. That process is much shorter (I'd have to mine my emails for the time window she suggested). Then after learning if have fibers intact you would at least know if more therapy would have utility.

Back to getting the name of the clinic in Florida I think i'll send an email to the Rutgers folks to get it.
cheers all!

[ncs91]

Can you tell me the name of the clinic?

[skeaman]

The trial was approved by the FDA and was getting ready to launch when Covid hit. This shut it down, then the trial sponsor, StemCyte, backed out. Wise then found new sources of umbilical cord blood, and submitted a new IND to the FDA. Because we are using a new sources of cells, must prove the cells are safe. This means conducting an animal study that will cost over a million. About 5 years ago, Wise started a company to collect umbilical cord blood to use for sci and other disorders. Mononuclear Therapeutics is the new sponsor f the trial. Wise will use the profits to fund trials. He is working hard to raise the 20+
million for the trial.

You say it was approved by the FDA and was getting ready to launch when Covid hit. Can you say what cells was he going to use on this trial . . Like if he has got a new sponsor, surely he’ll go with the previous agreement that the FDA had approved and go with what he had before covid hit?

[parapete]

I hate to sound rude here but did you read the whole post? Stemcyte was the provider of the cells. They backed out and will not provide the cells after the original trial was approved. Therefore trial needed new source of cells and therefore new fda approval. We all frustrated but it is what it is.

[Sparky831]

This trial has faced so many setbacks man. I honestly don't see this trial ever happening in the USA!